2 August 2022
Genus plc
('Genus' or the 'Company')
Appointment of Joint Corporate Broker
Genus plc (LSE: GNS), a leading global animal genetics company, is pleased to announce the appointment of HSBC Bank plc ("HSBC") as its Joint Corporate Broker alongside Peel Hunt and Liberum, with immediate effect. The appointment is in addition to HSBC's existing role as Financial Adviser.
For further information, please contact:
|
Genus plc |
Tel: 01256 345970 |
|
Stephen Wilson, Chief Executive Officer |
|
|
Alison Henriksen, Chief Financial Officer |
|
HSBC Bank plc - Joint Broker and Financial Adviser |
Tel: 020 7991 8888 |
|
|
Adam Miller / James Hopton / Keith Welch |
||
|
Buchanan |
Tel: 0207 466 5000 |
|
|
Charles Ryland / Chris Lane / Sophie Wills |
||
This announcement is available on the Genus website www.genusplc.com
About Genus
Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.
Genus' worldwide sales are made in over seventy-five countries under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. Genus's customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chains.
The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.
With headquarters in Basingstoke, United Kingdom, Genus companies operate in over twenty-five countries on six continents, with research laboratories located in Madison, Wisconsin, USA.